Motivation: Understanding how gene regulatory networks change under different cellular states is important for revealing insights into network dynamics. Gaussian graphical models, which assume that the data follow a joint normal distribution, have been used recently to infer differential networks. However, the distributions of the omics data are non-normal in general. Furthermore, although much biological knowledge (or prior information) has been accumulated, most existing methods ignore the valuable prior information. Therefore, new statistical methods are needed to relax the normality assumption and make full use of prior information. Results: We propose a new differential network analysis method to address the above challenges. Instead of using Gaussian graphical models, we employ a non-paranormal graphical model that can relax the normality assumption. We develop a principled model to take into account the following prior information: (i) a differential edge less likely exists between two genes that do not participate together in the same pathway; (ii) changes in the networks are driven by certain regulator genes that are perturbed across different cellular states and (iii) the differential networks estimated from multi-view gene expression data likely share common structures. Simulation studies demonstrate that our method outperforms other graphical model-based algorithms. We apply our method to identify the differential networks between platinum-sensitive and platinum-resistant ovarian tumors, and the differential networks between the proneural and mesenchymal subtypes of glioblastoma. Hub nodes in the estimated differential networks rediscover known cancer-related regulator genes and contain interesting predictions. Availability and Implementation: The source code is at https://github.com/Zhangxf-ccnu/pDNA Contact:
Introduction
Biological processes involve complex interactions between biochemical entities (Barab asi et al., 2011) . Molecular regulators and their target genes interact with each other to form gene regulatory networks (GRNs) that play an important role in biological processes (Zhao et al., 2016) . It is acknowledged that GRNs often undergo changes between different cellular states [e.g. environment conditions (Bandyopadhyay et al., 2010; Califano, 2011; Mitra et (Greene et al., 2015; Marbach et al., 2016) and/ or disease states (Ha et al., 2015) ]. Therefore, the focus of network analysis has shifted from inferring GRNs (Marbach et al., 2012; Zhang et al., 2013) to identifying GRN rewiring between different cellular states (Gill et al., 2010; Ideker and Krogan, 2012; Zhao and Chen, 2014; Qin and Zhao, 2014) . Indeed, differential network analysis, which measures the changes in network structure, has recently emerged as an important complement to differential expression analysis (de la Fuente, 2010; Lichtblau et al., 2016) . In recent years, numerous gene expression datasets have been published and they provide a great opportunity to measure the changes of GRNs between different states. GRNs are often modeled by Gaussian graphical models (Koller and Friedman, 2009) , where the gene expression levels are assumed to follow a multivariate normal distribution. Based on Gaussian graphical models, a GRN can be determined directly from the precision matrix (inverse covariance matrix; Werhli et al., 2006) . There is a direct regulatory interaction between two genes if and only if the corresponding entry of the precision matrix is non-zero. The differential network between two state-specific GRNs can be modeled as the difference between the corresponding precision matrices .
There are currently two main types of Gaussian graphical model-based differential network analysis methods. The first type of methods first estimate the state-specific precision matrices and then compute the difference between the two estimated precision matrices (Danaher et al., 2014; Mohan et al., 2014; Ha et al., 2015; Grechkin et al., 2016; Zhang et al., 2016) . The second type of methods directly estimate the precision matrix difference without estimating the individual precision matrices Yuan et al., 2015; Tian et al., 2016) . Since estimating the precision matrix difference directly only needs half sample size as compared to estimating the individual precision matrices separately, the latter type of methods often outperforms the former type (Tian et al., 2016) .
Although the above methods have successfully addressed some biological problems, they have several drawbacks. Normality assumption of Gaussian graphical models is one of their limitations (Liu et al., 2009 (Liu et al., , 2012 Xue et al., 2012) . In reality, we often face non-normal data. Even for typical log ration expression values from microarray data, the normality assumption is also inappropriate (Xue et al., 2012) . Without normality, the precision matrix cannot be translated into an interpretable graphical model. In addition, previous graphical model-based methods do not consider the prior knowledge learned from biomedical research. First, researchers have found that two genes that do not belong to the same pathway are less likely to be connected in any state specific GRNs, and thus also less likely to be connected in the corresponding differential network (Wang et al., 2013; Grechkin et al., 2015) (Fig. 1A) . Second, the changes of networks may be due to certain regulator genes that are perturbed across states and therefore have completely different regulatory relationships with other genes (Mohan et al., 2014) . For example, cancer driver mutations on a transcription factor can change its interactions with many target genes, disrupting the structure of GRNs (Grechkin et al., 2016) (Fig. 1A) . Previous works usually assume that the difference between two state-specific GRNs is driven by individual edges, which could not fully exploit the prior knowledge. Third, rapidly evolving technologies allow us to measure gene expression levels using different omic technologies and experimental platforms. For example, besides mRNA expression data, copy number variation and DNA methylation can also provide information of gene expression levels (Huang et al., 2012; Wagner et al., 2014) . Consequently, gene expression levels for the same subjects can be quantified from multiple attributes. Large-scale efforts by The Cancer Genome Atlas (TCGA) have already provided such multi-view gene expression data for thousands of cancer patients. Previous differential network analysis methods can only be applied to a single-view data, ignoring the complementary nature of the information provided by multi-view data (Fig. 1B) .
In this paper, we develop a new graphical model-based method to address the above problems. To relax the normality assumption, we use the non-paranormal graphical model (Liu et al., 2009 ). Then we propose a prior information-dependent differential network analysis (pDNA) method by combining a D-trace loss function and a hierarchical group bridge penalty function. The D-trace loss function allows us to estimate the precision matrix difference directly (Yuan et al., 2015) . The hierarchical group bridge penalty function can incorporate pathway-based constraints, capture regulator genes that drive the changes of networks, and borrow strength across different data types to jointly estimate multiple differential networks. Fig. 1 . Structures on the differential networks. (A) State-specific GRNs and their differential network for a single view data. There are two pathways, fX1; X2; X3g and fX3; X4; X5; X6g. Gene X 3 is shared by the two pathways. A pair of genes that do not work together in any of the pathways are less likely to have a regulatory interaction in both cellular states (left and middle), and therefore are unlikely to be connected in the differential network (right). In addition, network differ due to two key genes, X 3 and X 6 , which are perturbed across states. Thus, the resulting differential network is determined by certain hub nodes. (B) Adjacency matrices of differential networks corresponding to different views of data. Due to the common information provided by multi-view gene expression data, it is reasonable to assume that the differential networks corresponding to different views have similar network structures
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We first illustrate the performance of our method by comparing with other graphical model-based methods on simulated datasets. We then apply our method to TCGA data to identify the differential networks associated with platinum resistance in ovarian cancer and the differential networks associated with molecular classification of glioblastoma. The hub genes in the estimated differential networks between platinum-sensitive and platinum-resistant ovarian tumors play a critical role in developing resistance to platinum-based chemotherapy, and the hubs in the estimated differential network between the proneural and mesenchymal subtypes are useful for the characterization of subtypes of glioblastoma.
Materials and methods

Brief review of the non-paranormal graphical model
The non-paranormal graphical model is an extension of the Gaussian graphical models by relaxing the assumption of normality (Liu et al., 2009 Yuan et al., 2015; Tian et al., 2016) .
Notations and problem statement
Here, we briefly introduce some notations that will be used throughout this paper. We assume that there are n ¼ n 1 þ n 2 subjects divided into two groups, where n c (c ¼ 1; 2) denotes the number of subjects in the c-th group. For each subject, we observe gene expression levels for p genes from K different views (e.g. different omic technologies and/or experimental platforms). Let X kc be an n c Â p matrix that denotes the gene-level activities collected from the k-th view over subjects in the c-th group, where the ð'; iÞ-th element, X index groups of subjects using c ¼ 1, 2 and index subjects in each group using ' ¼ 1; . . . ; n c . We let hA; Bi ¼ trðAB T Þ.
In this study, we focus on exploring how GRNs undergo changes between two different cellular states using multi-view gene expression data. Mathematically, suppose we observe 2K data matrices, fX kc g, for p genes over two groups of subjects from K views ( Supplementary Fig. S1A ). Our goal is to estimate the K differential networks between the two groups of subjects for the K views using the non-paranormal graphical model. That is, we aim to estimate the precision matrix difference, fD k g. Our method includes two steps. First, we compute a sample estimate of fR kc g using a rankbased correlation ( Supplementary Fig. S1B ). As the second step, we propose a prior information-dependent differential network analysis method to directly estimate fD k g, which does not require the separate estimate of the individual precision matrices ( Supplementary  Fig. S1C ). Prior information are incorporated in this step to impose structures of interest on the resulting differential networks.
Sample non-paranormal covariance matrix estimation
For each subject group and each data view, we assume that the gene expression levels follow a non-paranormal distribution, i.e. X $ NPNðf kc ; R kc Þ. Given the observed gene expression data matrix, X kc , we can compute the sample non-paranormal covariance matrix, b R kc , using a rank correlation (e.g. Kendall's tau correlation), without explicitly calculating the marginal transformation functions f kc (Liu et al., 2012; Xue et al., 2012) . The Kendall's tau correlation between genes i and j, denoted by b s kc ij , is computed as:
By exploiting the relation between Pearson's correlation and Kendall's tau correlation, the underlying sample covariance matrix of the transformed data can be computed as:
It has been proven that b R kc is a good estimator of R kc and can be used to infer a graphical model (Liu et al., 2012; Xue et al., 2012) . We compute the sample non-paranormal covariance matrices, f b R kc g, for the two groups of subjects and the K views of data ( Supplementary Fig. S1B ), and use them to infer differential networks. Note that although we compute the sample covariance matrices using the Kendall's tau correlation, the Spearman's rho correlation can be used as well.
Prior information-dependent differential network analysis model
Let f b R kc g be the sample non-paranormal covariance matrices computed as above. To estimate the precision matrix difference for the K views,
, we extend the D-trace loss function introduced by Yuan et al. (2015) from single-view data to multi-view data,
Minimizing LðfD k gÞ will produce estimate b D
for k ¼ 1;...;K if the sample non-paranormal covariance matrices are positive definite. However, when the number of genes is larger than the number of subjects, f b R kc g are often not invertible and obtaining an accurate estimate of fD k g is challenging.
In order to improve the statistical power and interpretability, we consider incorporating prior biological information (or assumption) via a penalized estimation approach. In particular, we consider the following prior knowledge: (i) The groups of subjects are quite similar to each other but have important difference, therefore the statespecific GRNs are similar and the differential network between them is sparse Yuan et al., 2015; Tian et al., 2016) . (ii) A pair of genes would have a regulatory interaction only if they co-occur in at least one pathway (Grechkin et al., 2015) . Therefore, it is reasonable to assume that two genes cannot be connected in state-specific GRNs if they do not co-occur in any pathways and therefore cannot be connected in the corresponding differential networks. (iii) The difference between two state-specific GRNs is driven by certain regulator genes (e.g. transcription factors) that regulate hundreds of downstream genes but are mutated in a particular condition, completely disrupting their functional dependencies with other genes. Thus, the differential networks include certain hub genes (Mohan et al., 2014) . iv) Gene expression levels collected from different views of data contain complementary information. The differential networks estimated from these multi-view data might share certain network structures. Jointly estimating multiple differential networks by integrating information across different views can improve the accuracy.
To make full use of these prior knowledge, we propose a hierarchical group bridge penalty function
where F is a co-pathway indication matrix with F ij ¼ 1 if genes i and j co-occur in at least one pathway and F ij ¼ 0 otherwise. To incorporate pathway-based constraints, we set V
T following the idea of row-column overlap norm penalty (Mohan et al., 2014; Tan et al., 2014) , where V k is not required to be symmetric. In doing so, we can impose structures of interest on the columns and rows of D k by penalizing the columns of V k , encouraging the appearance of hub nodes in the resulting differential networks. The proposed penalty function (4) is an extension of the group bridge penalty (Huang et al., 2009; Guo et al., 2011) , which is designed for selecting variables at both the group and within-group individual variable levels, from two to three levels. To integrate information from different views of data, for each pair of genes (i, j), we treat the K parameters fV 1 ij ; . . . ; V K ij g corresponding to the K views as a group. To explicitly capture hub nodes, for each genes j, we consider the pK parameters ffV By combining the D-trace loss function (3) and the hierarchical group bridge penalty function (4), we develop a prior informationinduced differential network analysis (pDNA) model:
where k is a non-negative tuning parameter. Here we add the constrain D k ¼ ðD k Þ T to make the estimate symmetric. The choice of k controls the sparsity of the resulting differential networks, which requires tuning. We present the parameter selection strategy in Section 2.5. Let f b D k g denote the solution to (5), which serves as the K estimated differential networks corresponding to the K views of data. Due to the lack of space, the details of solving (5) 
Tuning parameter selection
For pDNA (5), tuning parameter k controls the sparsity of the resulting differential networks. Large k yields sparse differential networks and small k yields dense differential networks. The selection of k is critical. In most applications, differential network estimation is performed as a part of exploratory data analysis and hypothesis generation. Tuning parameter selection should be guided by practical considerations, such as network interpretability, stability and sparsity. Thus, we determine the value of k via stability selection, which simultaneously takes into account of the sparsity and stability of the resulting networks (Meinshausen and Bü hlmann, 2010; Liu et al., 2010) . Details are provided in Supplementary Section S2.5.
Simulation study
Data generation
In this simulation, we consider K ¼ 6 views of data. We generate 12 networks with p ¼ 100, 200 genes for the two groups of subjects and six views of data. Each network consists of two pathways with 0:6p genes per pathway, and there are 0:2p genes shared by the two pathways. Each pathway is generated as a scale-free network since many biological networks have been reported to be scale-free (Barab asi, 2009) . To model genes that drive the changes of networks, m of the p genes are considered as perturbed genes. For each perturbed gene, we assume that it can drive q 1 p differential edges, where q 1 is the proportion of differential edges driven by perturbed genes. A higher q 1 will produce more differential edges. To model heterogeneity to the common structure of differential network for each view, we choose a proportion (q 2 ) of differential edges to be view-specific. Consequently, each perturbed gene produces q 1 ð1 À q 2 Þp differential edges shared by all the K views, and q 1 q 2 p differential edges that only occur in a specific view. We do not generate differential edges between two genes in different pathways. That is, a pair of nodes cannot be connected to each other in the differential networks if they do not co-occur in any pathways. An example of the simulated GRNs and differential networks is shown in Supplementary Figure S2 . To make a fair comparison with Gaussian graphical model-based methods, the gene expression levels of subjects are simulated using a multivariate normal distribution. Details are provided in Supplementary Section S2.6. We set proportion of differential edges q 1 ¼ 0:3; 0:5; 0:7; 0:9 and proportion of view-specific differential edges q 2 ¼ 0:1; 0:2. We set sample sizes n 1 ; n 2 ¼ 50; 100; 200 and number of perturbed nodes m ¼ 4 for p ¼ 100, and sample sizes n 1 ; n 2 ¼ 100; 200; 400 and number of perturbed nodes m ¼ 8 for p ¼ 200. We evaluate the performance of methods with each combination of n 1 ; n 2 , q 1 and q 2 .
Simulation results
We evaluate the performance of pDNA by comparing with the lasso penalized D-trace loss (D-trace) (Yuan et al., 2015) , the fused graphical lasso (FGL) (Danaher et al., 2014) and the perturbed-node joint graphical lasso (PNJGL) (Mohan et al., 2014) on simulated data. We implement the alternating direction algorithm for D-trace in MATLAB by ourselves. For FGL, we use the JGL function with 'penalty ¼ fused' from the R package JGL. The MATLAB code of PNJGL is obtained from (Mohan et al., 2014) . FGL and PNJGL have two parameters, k 1 and k 2 , which control the sparsity of the resulting state-specific networks and differential networks, respectively. Since we focus on estimating differential networks, we set k 1 ¼ 0 following the previous studies Yuan et al., 2015) . D-trace, FGL and PNJGL are not designed for multi-view data, differential networks are therefore estimated for each view separately. More details of the compared methods are presented in Supplementary Section S2.3.
The performance is evaluated using precision-recall curve. Let b D , and let D ij be the (i, j)th entry of the true D k , then precision and recall can be defined as:
respectively. Here 1fÁg is an indicator function. For each method, we run it with different values of tuning parameter (k for pDNA and D-trace, k 2 for FGL and PNJGL) that controls the sparsity of the resulting differential networks. The precision-recall curve is used to quantify the performance as a function of the tuning parameter. Figure 2 shows the results, averaged over 50 random generations of the data, with different n 1 ; n 2 and q 1 when p ¼ 100 and q 2 ¼ 0:1. Each row corresponds to a sample size (n 1 or n 2 ) while each column corresponds to a proportion of differential edges (q 1 ). Within each plot, each colored line corresponds to the results of a method as the tuning parameter is varied, an each point represents a value of the tuning parameter. We observe that pDNA substantially outperforms D-trace and FGL. Our pDNA also performs better than PNJGL when q 1 is small (q 1 ¼ 0:3; 0:5). When q 1 is large (q 1 ¼ 0:7; 0:9), the precision of pDNA is higher than that of PNJGL when we focus on the top predictions (recall < 0:8). The advantages of pDNA over other methods become more significant when the sample size decreases, indicating that pDNA can improve the accuracy of the estimated differential networks by making full use of prior knowledge. The results with q 2 ¼ 0:2 for p ¼ 100 ( Supplementary Fig. S3 ), and p ¼ 200 (Supplementary Figs S4 and S5 ) also show that pDNA outperforms existing methods.
TCGA ovarian cancer application
Datasets
Mainly due to resistance to platinum-based combination chemotherapy, patients with high-grade serous ovarian cancer have experienced little improvement in overall survival during the past 30 years (Bowtell et al., 2015) . To understand the drivers of platinum resistance, we identify the changes of GRNs between ovarian tumors with different treatment responses, platinum-sensitive and platinumresistant. We consider six gene expression datasets (with three from transcriptome, two from genome and one from epigenome) in TCGA which quantify the activity (expression) of genes from different views (The Cancer Genome Atlas Research Network, 2011). For transcriptome data, we consider the mRNA expression profiles collected using three platforms: Agilent 244K Custom Gene Expression G450, Affymetrix HT Human Genome U133 Array Plate Set, and Affymetrix Human Exon 1.0 ST Array. For genome data, we consider two types of copy number changes (Genome-Wide Human SNP Array 6.0) which provides somatic copy number alterations and copy number variants. The segments of copy number changes are merged at gene-level with reference genome build hg19. For epigenome data, we consider the methylation data collected using the Infinium HumanMethylation27 platform. Following Ha et al. (2015) , CpG sites are mapped to gene symbols by taking the first principal component if several sites correspond to a gene. The six datasets (level 3) are downloaded from the TCGA website (version: March 2, 2016). Gene expression levels of 8417 genes for 512 ovarian tumors across all the six datasets are available. More details of the six gene expression datasets are provided in Supplementary Section S2.8.
We adopt a similar criterion used by Nabavi et al. (2016) to classify tumors into resistant and sensitive groups. Tumors that do not have a sign of progression or recurrence within 6 months after the last treatment are defined as platinum-sensitive, and tumors that are recurred within 6 months after the last treatment are defined as platinum-resistant. We obtain the sensitive and resistant information for each tumor from (Zhang et al., 2016) . Among the 512 tumors, there are 243 platinum-sensitive tumors and 97 platinum-resistant ones. To analyze pathway aberrations, we perform a pathway-based analysis. We analyze genes in seven critical pathways involved in platinum resistance: apoptosis, cell cycle, ErbB signaling pathway, mismatch repair, nucleotide excision repair, p53 signaling pathway and platinum drug resistance (Dilruba and Kalayda, 2016) . We download these pathways from the Kyoto Encyclopedia of Genes and Genomes database (Kanehisa and Goto, 2000) . There are 315 genes in our gene expression datasets.
Differential network analysis
We apply our method to the six gene expression datasets described above. We first compute the group-specific non-paranormal sample covariance matrices according to (2), and then use them as the input of pNDA (5). The co-pathway indication matrix F is constructed using the seven pathways. The tuning parameter k is selected from a total of 20 possible values equally spaced between 0.05 and 1. According to the stability selection (Supplementary Section S2.5), we set k ¼ 0:35.
We find that 247 differential edges involving 178 genes are detected in at least one of the six datasets (Fig. 3) . Each dataset covers a large proportion of differential edges (165-198 edges) ( Supplementary Fig. S6A ). Most of the differential edges identified by pDNA are common to all six datasets ( Supplementary Fig. S6B ), indicating that pDNA can identify common network structures shared by different views of data. To further investigate the resulting differential networks, we combine the six estimated differential networks into a single weighted network W, where
That is, W ij is the number of datasets in which a pair of genes i and j is identified as a differential edge. We compute the degree for each gene in the weighted differential network,
There are a few high-degree nodes and most nodes have low-degrees (Fig. 3, Supplementary Fig. S6C ). The reason for this is that pDNA is designed for capturing hub nodes in the differential networks that drive the changes of networks.
Hub nodes play a significant role in driving the underlying network (Zhang et al., 2015b) . Therefore, we would like to reveal the biological significance of hub nodes in our identified weighted differential network. We consider the top 10 genes with the largest degree as hubs. In order to study whether the hub genes contribute to platinum resistance in ovarian cancer, we collect six sets of functionally important genes. We obtain 161 cisplatin resistance-related genes and 758 drug resistance-related genes from the database of Genomic Elements Associated with drug Resistance (http://gear. comp-sysbio.org), 116 anti-cancer drug targets from the cancer drug resistance database (Kumar et al., 2013) , 572 cancer genes for which mutations have been causally implicated in cancer from the Cancer Gene Census database (Futreal et al., 2004) , 548 ovarian cancer genes from the ovarian cancer gene database (genes which have at least two evidences are considered) (Liu et al., 2015) and 3545 regulator genes (transcription factors, chromatin modifies, or perform other regulatory activity) which have been used in (Grechkin et al., 2016) . Out of the 10 hub genes, four of them are cisplatin resistance-related genes, seven of them are drug resistance-related genes, five of them are anti-cancer drug targets, five of them are genes mutated in cancer, eight of them are ovarian cancer-related genes and nine of them are regulator genes (Table 1 ). According to the Fisher's exact test, the set of hub genes is significantly enriched with these biologically important genes (Table 2) .
Due to the fact that the reference sets of functionally important genes are incomplete, a predicted hub gene that does not match any of the reference sets might be functionally important but previously uncharacterized in public databases as well. We manually check the biological roles served by the 10 hubs from published literature (Supplementary Section S2.9). We find that all 10 hubs act as regulator genes, and nine of them (except CCND2) are associated with platinum resistance in ovarian cancer. Previous studies have shown that CCND2 is associated with doxorubicin resistance in breast cancer (Smith et al., 2006) . Therefore, it is interesting to study whether CCND2 contributes to platinum resistance in ovarian cancer. 
Comparison with other methods
We compare pDNA with D-trace, FGL and PNJGL on the TCGA ovarian cancer data. For each method, we use the non-paranormal sample covariance matrices which are used by pDNA as input and run it separately for each dataset. In order to provide interpretable results, the tuning parameters of D-trace and FGL are selected to give the similar number of differential edges as those of pDNA. For PNJGL, the tuning parameter is selected to produce 10 hubs. According to this criterion, we set k ¼ 0:344 for D-trace, k 1 ¼ 0 and k 2 ¼ 0:153 for FGL and k 1 ¼ 0 and k 2 ¼ 3:05 for PNJGL. For each method, after obtaining the six differential networks corresponding to different datasets, we combine them into a single weighted differential network in a similar way to that of pDNA.
A common challenge in evaluating differential network analysis using real data is the lack of the gold standard. That is, we cannot obtain the true differential network between platinum-resistant tumors and platinum-sensitive tumors. Therefore, it is difficult to directly compare different methods in terms of the accuracy of the estimated differential networks. In this work, we adopt an alternative way. We assess the performance of a method by quantifying how the set of hub nodes in the estimated differential networks captures known functionally important genes such as cisplatin resistance-related genes, drug resistance-related genes, anti-cancer drug targets, cancer driver genes, ovarian cancer-related genes and regulator genes. It is our hypothesis that a method that works better in capturing functionally important genes might have better performance in inferring differential networks. For all methods, we consider the top 10 genes with the highest degree as hubs.
From Table 2 , we observe that the set of hub genes identified by pDNA includes more functionally important genes than those identified by the other three compared methods. In addition, the six types of functionally important genes significantly appear in the set of hub genes identified by pDNA (Fisher's exact test, P-value < 0.05). On the other hand, only cancer genes (CG) is enriched in the set of hubs identified by D-trace, and only ovarian cancer genes (OCG) significantly appear in the set of hub genes identified by FGL. The set of hub genes determined by PNJGL does not significantly enriched with any type of functionally important genes.
TCGA glioblastoma application
Datasets
Glioblastoma is the first cancer type studied systematically by TCGA. Four subtypes of glioblastoma have been identified: classical, proneural, mesenchymal and neural (Verhaak et al., 2010) . The proneural subtype has high rates of alterations in TP53, PDGFRA Fig. 3 . The weighted differential network between platinum-sensitive and platinum-resistant ovarian tumors estimated by our method with k ¼ 0:35. The width of an edge is proportional to the number of datasets in which a differential edge is identified. The node size is proportional to the node's degree. There are certain hub nodes that drive the underlying network Table 1 . List of hub nodes in the weighted differential network between platinum-sensitive and platinum-resistant ovarian tumors estimated by our method
Note: If a gene is a cisplatin resistance-related gene (CR), drug resistancerelated gene (DR), anticancer drug target (ADT), cancer gene (CG), ovarian cancer gene (OCG) or regulator gene (RG), the corresponding entry is marked by a cross 'Â'. The abbreviation of functionally important genes is explained in Table 1 . b In aðbÞ, a and b denote the number of functionally important genes in our considered datasets and the number of functionally important genes obtained from corresponding databases, respectively. c In cðdÞ, c and d denote the number of hub nodes that are functionally important and the P-value that quantifies the enrichment of hub nodes among functionally important genes, respectively. and IDH1, and the mesenchymal subtype is characterized by frequent mutations in NF1. We apply pDNA using TCGA data to identify the differential networks between the proneural and mesenchymal subtypes. We consider three mRNA expression profiles collected from three platforms (Agilent 244K Custom Gene Expression G450, Affymetrix HT Human Genome U133 Array Plate Set, and Affymetrix Human Exon 1.0 ST Array) and two types of copy number change profiles related to somatic copy number alterations and copy number variants. We obtain the five datasets from the TCGA website (version: February 27, 2016) . Gene expression levels of 10 474 genes for 411 tumors across all the five datasets are available. The subtype information for tumors are obtained from (Brennan et al., 2013) . Among the 411 tumors, there are 77 proneural tumors and 119 mesenchymal tumors. We take a pathway-based analysis and focus on the RTK/PI3K, p53, Rb signaling pathways which consist of the most frequently altered genes in glioblastoma. We obtain the 49 genes involved in those pathways from (Ha et al., 2015) .
Differential network analysis
We apply pDNA to the five gene expression datasets. Here we do not consider the pathway-based constraints and set the co-pathway indication matrix F as a matrix of ones. We set the tuning parameter k ¼ 0:55 according to the stability selection. Like the results obtained from the ovarian cancer datasets, different types of data capture similar number of differential edges ( Supplementary Fig.  S7A ), and most of these edges are shared by all the five datasets ( Supplementary Fig. S7B ). We also compute a weighted differential network by combining the five differential networks corresponding to different views and evaluate the degree of each node. The weighted differential network includes several high-degree nodes and many low-degree nodes (Supplementary Figs S7C and S8) .
We further investigate the biological significance of the hubs in the weighted differential network. The top four genes with the largest degree are considered as hubs (Table 3) . Among the four hubs, PDGFRA and CDK4 are markers for the proneural subtype (Verhaak et al., 2010; Guan et al., 2014) . PDGFRA and CDK4 amplifications are observed in proneural tumors. Our method identifies PDGFRA and CDK4 as hubs, indicating that PDGFRA and CDK4 would be regulator genes that drive the changes of GRNs between the proneural and mesenchymal subtypes. FGFR fusions can identify a subtype of glioblastoma patients who would benefit from targeted FGFR kinase inhibition (Singh et al., 2012) , and FGFR1/3 tyrosine kinase fusions can define a subtype of non-small cell lung cancer (Wang et al., 2014) . SRC is a proto-oncogene and a number of tyrosine kinase inhibitors that target c-Src tyrosine kinase have been developed (Musumeci et al., 2012) . Marziali et al. (2016) recently found that SRC is a biomarker that defines two glioblastoma subtypes with different clinical outcome.
We compare pDNA with D-trace, FGL and PNJGL in terms of the hubs (the top four nodes with the largest degree) in the estimated differential networks. The tuning parameters of the compared methods are determined in a similar way to those used for analyzing the ovarian cancer datesets. We set k ¼ 0:358 for D-trace, k 1 ¼ 0 and k 2 ¼ 0:169 for FGL, and k 1 ¼ 0 and k 2 ¼ 2 for PNJGL. We find that the hubs identified by FGL are the same to those identified by pDNA (Table 3) . SRC and PDGFRA are also selected as hubs by Dtrace. The hubs identified by PNJGL are different from those identified by the other three methods. SRC is identified as a hub by three of the four methods and FGFR1 is identified as a hub by two of the four methods. Therefore, we conjecture that these two genes are associated with the changes of GRNs between the proneural and mesenchymal subtypes.
Discussion
In this work, we have introduced a method to infer the differential network between two different cellular states. The competitive performance of our method is demonstrated using both simulated and real data. The novelty of our method lies in taking the advantage of the non-paranormal graphical model and imposing structures of interest on the differential networks. The usage of the non-paranormal graphical model can relax the normality assumption. Unlike the Gaussian model that assumes the gene expression levels are distributed according to a multivariate normal distribution, the non-paranormal model assumes that the gene expression levels follow a joint normal distribution after a set of unknown monotone transformations. Therefore, our method is more flexible than the Gaussian graphical model-based ones. Moreover, we have proposed a hierarchical bridge group penalty to learn structures of interest of the differential networks. First, motivated by the incorporation of pathway information into GRN inference, we impose pathway-based constraints on the differential networks to improve the accuracy and interpretability. Second, rather than assuming that the difference between networks is driven by individual edges, our model assumes that the networks differ due to certain regulator genes that are perturbed. By taking the idea of row-column overlap norm, our penalty function encourages the appearance of hub nodes in the estimated differential networks. Therefore, our model can effectively identify key players that drive the changes of networks. Third, we consider the problem of jointly estimating multiple differential networks from multi-view gene expression data. In order to integrate information across multiple datasets, the proposed penalty encourages a similar pattern of sparsity across all precision matrix difference. Compared with methods that estimate individual differential network separately, our joint estimate method can exploit the common information provided by different views of data.
Besides graphical models, correlation-based methods have also been used to infer GRNs and differential networks. It is known that traditional correlation (e.g. Pearson correlation coefficient, mutual information) cannot distinguish direct interactions and indirect associations (Barzel and Barab asi, 2013; Feizi et al., 2013) . To address this issue, several partial correlation-based methods have been prosed recently (Zhang et al., 2012 (Zhang et al., , 2015a Zhao et al., 2016) . Compared with graphical model-based methods, correlation-based methods are easy to understand and can be implemented efficiently. However, for correlation-based methods, the group-specific correlations are estimated separately using subjects within each group, ignoring the similarity between the two group-specific GRNs. Therefore, we use a graphical model which formulates the differential network estimation problem as a statistical learning problem. The similarity between the two groups can be exploited by imposing (25) a sparsity penalty on the precision matrix difference. In addition, other structures of interest can be easily imposed on the resulting differential networks using a reasonable penalty function. We jointly estimate multiple differential networks which correspond to different but related views of data, following the idea of joint graphical lasso models (Guo et al., 2011; Danaher et al., 2014) . The common information shared by different views of data are incorporated via the developed hierarchical group bridge penalty function. Note that our method is developed to infer multiple differential networks for all views of data. We do not learn a unified differential network from multiple types of data. Multiple kernel learning is a popular method for learning a unified network (Speicher and Pfeifer, 2015) . Based on the idea of multiple kernel learning, we will study how to learn a unified differential network by integrating multiple types of data in the future study. Furthermore, we can learn the influence of each type of data on the final differential network.
One limitation of our method is the assumption of the non-paranormal distribution. The non-paranormal model is tailored for modelling continuous data that can be normal distributed after monotonic univariate transformations. However, there are many discrete data in genomic research. For example, gene expression levels from nextgeneration sequencing that counts how many times a transcript maps to a specific genomic location follow a Poisson distribution, and types of mutation can be modeled with multinomial or categorical distributions. In the future, we will extend our model to deal with discrete data using exponential family graphical models (Yang et al., 2015) .
